News
Important Only
Abeona Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Abeona Therapeutics Inc ABEO.OQ reported a quarterly adjusted loss of 14 cents per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -77 cents. The mean expectation of six analysts for the quarter was for a loss of 35 cents per share...Reuters
Thu, Mar 20
4 Things You Need to Know if You Buy Moderna Stock Today
It's been nearly five years since Moderna (NASDAQ: MRNA) emerged as a biotech industry disruptor, with its COVID-19 vaccine playing a landmark role in tackling the global pandemic in late 2020. Despite its generating record sales and profits through 2022, early projections of sustained demand for co...The Motley Fool
Thu, Mar 20
Microchip dips after launching $1.35 bln convertible stock offering
** Microchip Technology's MCHP.O shares down 3.6% at $52.58 before the bell as co plans capital raise to reduce debt** Chandler, Arizona chipmaker late Weds launched $1.35 bln 3-yr mandatory convertible preferred stock offering** It plans to use portion of net offering proceeds to pay for capped...Reuters
Thu, Mar 20
Pepsi, Poppi, and the Creosote Bush
In this podcast, Motley Fool analyst David Meier and host Dylan Lewis discuss:February retail numbers showing continued consumer struggles, and why this upcoming retail earnings season will be a key read on the economy.Pepsi's planned $2 billion acquisition of the Poppi soda brand, whose drinks incl...The Motley Fool
Thu, Mar 20
1 Wall Street Analyst Thinks Norwegian Cruise Line Stock Is Going to $30. Is It a Buy Around $20?
One Wall Street analyst thinks investors can book some nice profits by investing in Norwegian Cruise Line (NYSE: NCLH) stock right now. That's because demand for booking cruise vacations looks to be strong for at least the next year.This comes as travel stocks have been getting crushed during the ma...The Motley Fool
Thu, Mar 20
Eyenovia falls after plans to merge with private firm Betaliq
** Shares of eye-disease focused Eyenovia EYEN.O fall 2.4% to $1.63 premarket** Co says it is exploring a reverse merger with privately held Betaliq to combine their eye-disease focused operations** The proposed deal values Betaliq at around $77 million and Eyenovia at about $15 million** EYEN will ...Reuters
Thu, Mar 20
Starbucks Stock Is Down 15% This Month. Time to Buy?
Coffee giant Starbucks (NASDAQ: SBUX) could use some Wall Street caffeine these days.As of this writing on March 18, the stock is down 15% since the end of February. The broader market is also swooning with a 5.6% S&P 500 (SNPINDEX: ^GSPC) decline in the same period, but Starbucks is taking a deeper...The Motley Fool
Thu, Mar 20
Jabil jumps on raising annual forecasts, upbeat quarterly results
** Shares of electronic components maker Jabil JBL.N up 5.4% at $147 premarket** Co raises annual revenue and adjusted profit forecasts** CEO Mike Dastoor says co's designation as a U.S.-domiciled manufacturing services provider and significant U.S. footprint is becoming increasingly important f...Reuters
Thu, Mar 20
Darden Restaurants misses quarterly sales estimates as demand weakens
March 20 (Reuters) - Olive Garden-parent Darden Restaurants DRI.N missed Wall Street estimates for quarterly same-store sales on Thursday, as diners pulled back on eating out amid rising costs of living.The company posted third-quarter comparable sales growth of 0.7%, missing analysts' estimates...Reuters
Thu, Mar 20
2 Leading Tech Stocks to Buy in 2025
They say a rising tide lifts all boats. Well, the reverse is true, too: A falling tide lowers all boats. As it is in the water, so it is in the stock market. Case in point: As of this writing, the tech-heavy Nasdaq Composite (NASDAQINDEX: ^IXIC) has fallen by more than 9% year to date. As the index ...The Motley Fool
Thu, Mar 20
European defence stocks slip after record run
** Shares in European defence companies slip on Thursday, with an analyst pointing to profit taking after their record-breaking run ** Europe's aerospace and defence index .SXPARO is set for its biggest daily drop in 2 years, down 2.8% at 1155 GMT after hitting a fresh record high on Wednesday ...Reuters
Thu, Mar 20
MS starts coverage on Celldex, bullish view on company's skin disease treatment
** Morgan Stanley stars coverage on Celldex Therapeutics CLDX.O with "overweight" rating and PT of $46, citing the co's "pipeline potential in alternative mast cell-mediated diseases" and a "risk/reward that is skewed to the upside"** PT represents a 130.7% upside to stoc...Reuters
Thu, Mar 20
ProKidney Corp reports results for the quarter ended December 31 - Earnings Summary
ProKidney Corp PROK.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -9 cents. The mean expectation of six analysts for the quarter was for a loss of 15 cents per share. Wall Stre...Reuters
Thu, Mar 20
Is Broadcom Primed to Take Over Nvidia's Market Share? 1 Jaw-Dropping Projection That Investors Must Be Aware Of.
Nvidia (NASDAQ: NVDA) has dominated the artificial intelligence (AI) computing hardware game for the entirety of the AI arms race, but there's one company aiming to change that: Broadcom (NASDAQ: AVGO). While Nvidia's graphics processing units (GPUs) are best-in-class, Broadcom is looking to challen...The Motley Fool
Thu, Mar 20
Late to Retirement Planning? 7 Strategies to Help You Catch Up to Your Peers
If you're behind in your saving and investing for retirement, you're not alone. According to the 2024 Retirement Confidence Survey, fully 47% of workers have less than $100,000 socked away, and 29% have less than $25,000. Yikes!Even if you have, say, $500,000 saved, that might be far from enough. Af...The Motley Fool
Thu, Mar 20
US STOCKS-Futures slip as Fed boost proves short-lived
Weekly jobless claims data due at 8:30 a.m. ETAccenture gains after upbeat annual revenue forecastFutures off: Dow 0.35%, S&P 500 0.45%, Nasdaq 0.60%By Pranav Kashyap and Johann M Cherian March 20 (Reuters) - U.S. stock index futures reversed early gains on Thursday, as worries about the ...Reuters
Thu, Mar 20
Citi ups PT on LENZ Therapeutics on eye-drop approval confidence
** Citi hikes PT on LENZ Therapeutics LENZ.O by $3 to $47, 2nd-highest on Wall St and 84% higher vs $25.52 last close** Citi keeps "buy" rating, still seeing "high likelihood" of approval for LENZ'z LNZ10 eye drop for people with presbyopia** FDA decision expected in Aug, but Cit...Reuters
Thu, Mar 20
3 Once-Promising Growth Stocks That Are Down 40% Since the 2020 Crash -- Can Any of Them Recover?
It's been five years since the 2020 market crash, when news of a global pandemic sent investors into a panic. For investors brave enough to buy amid that crash, the gains for many stocks have been significant since then. It was on March 16, 2020, that many stocks hit their lows. That day, the S&P 50...The Motley Fool
Thu, Mar 20
Better Beaten-Down Dividend Stock to Buy: Innovative Industrial Properties or Medical Properties Trust?
Real estate investment trusts (REIT) are a favorite target of income-seeking investors, since the law requires them to distribute most of their earnings as dividends to maintain their tax-advantaged status. However, even REITs face issues that put their dividend programs in danger, sometimes leading...The Motley Fool
Thu, Mar 20
